Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Lymphoma & Non-acute Leukemia W Cc (CDM CPKF251A4AEEA) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 18, 2026 , from http://ppman.hank.ai/transparency/procedure/CPKF251A4AEEA/by-state?code_type=CDM
“Lymphoma & Non-acute Leukemia W Cc (CDM CPKF251A4AEEA) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/CPKF251A4AEEA/by-state?code_type=CDM. Accessed
November 18, 2026 .
“Lymphoma & Non-acute Leukemia W Cc (CDM CPKF251A4AEEA) by State,” HANK Price Transparency ,
accessed November 18, 2026 ,
http://ppman.hank.ai/transparency/procedure/CPKF251A4AEEA/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
CPKF251A4AEEA — Lymphoma & Non-acute Leukemia W Cc
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$120,920
National median
$116,889 – $141,073
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for CPKF251A4AEEA (CDM), with interquartile range
State Median p25 p75
KY $120,920 $116,889 $141,073